| 摘要 |
<p>Pharmaceutical formulations, particularly suitable for treating chronic and neuropathic pain comprise an opioid-potentiating amount of a CCK antagonist and an analgesic amount of an opioid in a pharmaceutically acceptable biphasic carrier comprising an organic phase comprising a glyceride derivative and a hydrophilic phase.</p> |
